Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xethanol was a renewable energy company that specialized in the production of ethanol from biomass, specifically focusing on cellulosic ethanol technology. The company utilized industrial biotechnology, including the genetic engineering of yeast strains, to convert waste materials such as wood chips and agricultural residues into fuel. Founded in 2000 and headquartered in New York, Xethanol was a pioneer in the public biofuels market but struggled with technical viability and legal issues. In 2008, the company rebranded as Global Energy Holdings Group and shifted its focus to broader energy waste feedstocks before filing for bankruptcy in 2009.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xethanol.